<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006642.pub2" GROUP_ID="PVD" ID="108007022012554466" MERGED_FROM="" MODIFIED="2015-09-22 14:53:31 +0100" MODIFIED_BY="Marlene Stewart" REVIEW_NO="1191" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="3.0">
<COVER_SHEET MODIFIED="2015-09-22 14:53:31 +0100" MODIFIED_BY="Marlene Stewart">
<TITLE MODIFIED="2015-07-27 21:53:16 +0100" MODIFIED_BY="[Empty name]">Thoracic endovascular repair (TEVAR) versus open surgery for blunt traumatic thoracic aortic injury</TITLE>
<CONTACT MODIFIED="2015-09-22 14:53:31 +0100" MODIFIED_BY="Marlene Stewart"><PERSON ID="z1403101202497187299705019523535" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Dominic</FIRST_NAME><LAST_NAME>Pang</LAST_NAME><POSITION>Surgical Trainee</POSITION><EMAIL_1>dominic.pang@nhs.net</EMAIL_1><ADDRESS><ORGANISATION>NHS Grampian</ORGANISATION><ADDRESS_1>Foresterhill Road</ADDRESS_1><CITY>Aberdeen</CITY><ZIP>AB25 2ZN</ZIP><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2015-09-22 14:53:31 +0100" MODIFIED_BY="Marlene Stewart"><PERSON ID="z1403101202497187299705019523535" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Dominic</FIRST_NAME><LAST_NAME>Pang</LAST_NAME><POSITION>Surgical Trainee</POSITION><EMAIL_1>dominic.pang@nhs.net</EMAIL_1><ADDRESS><ORGANISATION>NHS Grampian</ORGANISATION><ADDRESS_1>Foresterhill Road</ADDRESS_1><CITY>Aberdeen</CITY><ZIP>AB25 2ZN</ZIP><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="z1407171338002242217255318829444" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Diane</FIRST_NAME><LAST_NAME>Hildebrand</LAST_NAME><POSITION>Registrar</POSITION><EMAIL_1>dianehildebrand@nhs.net</EMAIL_1><ADDRESS><ORGANISATION>NHS Grampian</ORGANISATION><ADDRESS_1>Foresterhill Road</ADDRESS_1><CITY>Aberdeen</CITY><ZIP>AB25 2ZN</ZIP><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="8984" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Paul</FIRST_NAME><LAST_NAME>Bachoo</LAST_NAME><POSITION>Consultant Surgeon and Clinical Lead Vascular Surgery</POSITION><EMAIL_1>paulbachoo@nhs.net</EMAIL_1><ADDRESS><DEPARTMENT>Department of Vascular Surgery</DEPARTMENT><ORGANISATION>NHS Grampian</ORGANISATION><ADDRESS_1>Foresterhill Road</ADDRESS_1><CITY>Aberdeen</CITY><ZIP>AB25 2ZN</ZIP><REGION>Scotland</REGION><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2015-07-31 07:36:49 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="30" MONTH="7" YEAR="2015"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="30" MONTH="7" YEAR="2015"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="30" MONTH="7" YEAR="2017"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2007"/>
<REVIEW_PUBLISHED ISSUE="9" YEAR="2015"/>
<LAST_CITATION_ISSUE ISSUE="9" YEAR="2015"/>
</DATES>
<WHATS_NEW MODIFIED="2012-12-10 09:32:59 +0000" MODIFIED_BY="[Empty name]"/>
<HISTORY MODIFIED="2015-09-22 08:55:33 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2015-09-22 08:55:33 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="23" MONTH="4" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2015-07-31 07:39:46 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES MODIFIED="2015-07-31 07:39:46 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2015-07-31 07:39:46 +0100" MODIFIED_BY="[Empty name]">
<NAME>Chief Scientist Office, Scottish Government Health Directorates, Scottish Government</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>The Cochrane Vascular editorial base is supported by the Chief Scientist Office.</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2015-09-22 13:58:13 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2015-09-22 13:42:03 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2015-07-30 20:31:32 +0100" MODIFIED_BY="[Empty name]">TEVAR versus open surgery for blunt traumatic thoracic aortic injury</TITLE>
<SUMMARY_BODY MODIFIED="2015-09-22 13:42:03 +0100" MODIFIED_BY="[Empty name]">
<P>
<U>Background</U>
</P>
<P>Blunt traumatic thoracic aortic injury (BTAI) caused by motor vehicle accident and blunt thoracic trauma is a surgical emergency with high mortality rate. Most patients do not survive long enough to reach the hospital. Two main treatment options for BTAI are open surgery and thoracic endovascular repair (TEVAR).</P>
<P>
<U>Study characteristics and key results</U>
</P>
<P>We performed a review of the literature (current up to July 2015) to determine whether use of TEVAR is associated with reduced death and illness when compared to open repair. We identified no randomised controlled trials on this topic. To perform a randomised controlled trial to clarify optimal management of BTAI would be very challenging to complete, mainly because of the natural history of the condition, usually seen in combination with other life-threatening injuries, the requirement for urgent intervention and the potential difficulties surrounding consent. Despite lack of RCT evidence, clinicians are moving forward with endovascular treatment of BTAI on the basis of meta-analyses and large clinical series.</P>
<P>
<U>Quality of the evidence</U>
</P>
<P>We found no studies undertaken to address our objectives; therefore we were not able to assess the quality of the evidence.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2015-09-22 13:43:35 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2015-09-22 13:43:35 +0100" MODIFIED_BY="[Empty name]">
<P>Blunt traumatic thoracic aortic injury (BTAI) is a life-threatening surgical emergency associated with mortality up to 8000 per year, most commonly caused by rapid acceleration/deceleration injury sustained through motor vehicle accident and/or blunt thoracic trauma. BTAI has high pre-hospital mortality following the primary injury, with only 10% to 15% of patients surviving long enough to reach the hospital. Open surgical repair had remained the standard treatment option for BTAI since successfully introduced in 1959. However, with technological advances, thoracic endovascular repair (TEVAR) offers an alternative treatment option for BTAI. TEVAR is a less invasive surgical approach for management of these already critical patients; many reports have described favourable early outcomes.</P>
<P>Thoracic endovascular repair may appear to be superior to open repair for treatment of BTAI. However, its long-term results and efficacy remain unknown. No randomised controlled trials (RCTs) have provided evidence to support the superiority of the endovascular approach versus open repair in the treatment of BTAI. This review aims to address this matter.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2015-09-22 08:45:51 +0100" MODIFIED_BY="[Empty name]">
<P>To determine whether use of TEVAR for treatment of BTAI is associated with reduced mortality and morbidity when compared with conventional open surgery.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2015-09-22 08:45:53 +0100" MODIFIED_BY="[Empty name]">
<P>The Cochrane Vascular Trials Search Co-ordinator searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2015, Issue 7) and clinical trials databases for details of ongoing and unpublished studies.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2015-09-22 08:45:54 +0100" MODIFIED_BY="[Empty name]">
<P>We considered all published and unpublished randomised controlled trials (RCTs) comparing TEVAR and open surgery for BTAI.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2015-09-22 08:50:54 +0100" MODIFIED_BY="[Empty name]">
<P>Two review authors independently reviewed all RCTs identified by the Trials Search Co-ordinator.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2015-09-22 08:45:56 +0100" MODIFIED_BY="[Empty name]">
<P>We found no RCTs that met the inclusion criteria for this review.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2015-09-22 13:41:03 +0100" MODIFIED_BY="[Empty name]">
<P>We found no RCTs conducted to determine whether use of TEVAR for the treatment of BTAI is associated with reduced mortality and morbidity when compared to conventional open repair. Hence, we are unable to provide any evidence to guide the treatment option for this life-threatening condition. To perform a randomised controlled trial to clarify the optimal management of BTAI would be highly challenging due to the natural history of the condition. Despite the lack of RCT evidence, clinicians are moving forward with endovascular treatment of BTAI on the basis of meta-analyses and large clinical series.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2015-09-22 13:58:13 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2015-09-22 13:46:58 +0100" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2015-09-22 13:44:06 +0100" MODIFIED_BY="[Empty name]">
<P>Blunt traumatic thoracic aortic injury (BTAI) is a life-threatening surgical emergency that is most commonly caused by rapid acceleration/deceleration injury sustained through motor vehicle accident and/or blunt thoracic trauma. In the United States, nearly 8000 deaths secondary to BTAI occur each year (<LINK REF="REF-Nagy-2000" TYPE="REFERENCE">Nagy 2000</LINK>). BTAI has a high pre-hospital mortality following the primary injury, with only 10% to 15% of patients surviving long enough to reach hospitals (<LINK REF="REF-O_x0027_Conner-2004" TYPE="REFERENCE">O'Conner 2004</LINK>). Among these patients, 99% would die without early diagnosis and surgical intervention (<LINK REF="REF-O_x0027_Conner-2004" TYPE="REFERENCE">O'Conner 2004</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2015-09-22 13:46:34 +0100" MODIFIED_BY="[Empty name]">
<P>Open surgical repair has been the standard treatment option for BTAI since it was successfully introduced in 1959 (<LINK REF="REF-Passaro-1959" TYPE="REFERENCE">Passaro 1959</LINK>). This procedure generally involves thoracotomy, single-lung ventilation, systemic anticoagulation, use of cardiopulmonary bypass and aortic cross-clamping. Although this procedure provides a chance of survival for this highly morbid condition, some aspects of open repair may serve to exacerbate co-existing injuries sustained, resulting in high postoperative mortality and frequent major postoperative complications (<LINK REF="REF-Cowley-1990" TYPE="REFERENCE">Cowley 1990</LINK>; <LINK REF="REF-von-Oppell-1994" TYPE="REFERENCE">von Oppell 1994</LINK>).</P>
<P>Thoracic endovascular repair (TEVAR) offers an alternative treatment option for BTAI. Since first introduced in 1991 for treatment of abdominal aneurysms (<LINK REF="REF-Parodi-1991" TYPE="REFERENCE">Parodi 1991</LINK>), TEVAR has been quickly adopted as treatment for BTAI (<LINK REF="REF-Dake-1994" TYPE="REFERENCE">Dake 1994</LINK>; <LINK REF="REF-Kato-1997" TYPE="REFERENCE">Kato 1997</LINK>). TEVAR offers a less invasive approach of treatment for these already critical patients; therefore, many reports describing favourable early outcomes are available in the literature (<LINK REF="REF-Orford-2003" TYPE="REFERENCE">Orford 2003</LINK>; <LINK REF="REF-Tehrani-2006" TYPE="REFERENCE">Tehrani 2006</LINK>). Thoracic endovascular repair involves meticulous preoperative planning with computed tomo-angiography (CTA) imaging to size stent grafts, gaining access to the thoracic aorta via an endovascular approach and deployment of the stent grafts in the thoracic aorta. Although TEVAR is a novel treatment compared with open surgery, severe complications may occur and these complications may be classified into two main categories: device-related complications (endoleak, stent graft migration, stent graft rupture) and ischaemic complications secondary to embolic events (stroke, paraplegia, spinal cord-related ischaemic injury) (<LINK REF="REF-Bavaria-2007" TYPE="REFERENCE">Bavaria 2007</LINK>; <LINK REF="REF-Feezor-2008" TYPE="REFERENCE">Feezor 2008</LINK>).</P>
</INTERVENTION>
<IMPORTANCE MODIFIED="2015-09-22 13:46:58 +0100" MODIFIED_BY="[Empty name]">
<P>Endovascular approach appears to be superior to open repair for treatment of BTAI. However, long-term results and efficacy of the endovascular approach remain unknown. We found no randomised controlled trial evidence to support superiority of the endovascular approach compared with open repair in the treatment of BTAI. This review aims to address this matter.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2015-09-22 08:46:31 +0100" MODIFIED_BY="[Empty name]">
<P>To determine whether use of TEVAR for treatment of BTAI is associated with reduced mortality and morbidity when compared with conventional open surgery.</P>
</OBJECTIVES>
<METHODS MODIFIED="2015-09-22 13:48:17 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2015-09-22 08:51:29 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2015-09-22 08:51:29 +0100" MODIFIED_BY="[Empty name]">
<P>Trials considered included randomised controlled trials already published and those still being conducted but reporting preliminary results. In addition, we considered randomised trials conducted by stent manufacturers (on file but not published) for inclusion in the review. Studies published in the English language were considered for inclusion in the review. We attempted to obtain translations of non-English language studies when necessary..</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2015-09-22 08:46:39 +0100" MODIFIED_BY="[Empty name]">
<P>We included in the review all participants with documented BTAI identified on chest computed tomographic scan or aortogram.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2015-09-22 08:46:50 +0100" MODIFIED_BY="[Empty name]">
<P>We planned to include randomised controlled trials that compared TEVAR versus conventional open surgery.</P>
<P>Both procedures (TEVAR and conventional open surgery) must have been performed within one week of the diagnosis of BTAI for the study to be eligible for inclusion in this review. We planned to extract the following information for analysis and comparison.</P>
<SUBSECTION>
<HEADING LEVEL="4">TEVAR</HEADING>
<UL>
<LI>Co-morbidities and associated lesions.</LI>
<LI>Time from diagnosis to repair.</LI>
<LI>Device type, diameter and length.</LI>
<LI>Type of access utilised.</LI>
<LI>Use of heparin.</LI>
<LI>Operating times.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Conventional open surgery</HEADING>
<UL>
<LI>Co-morbidities and associated lesions.</LI>
<LI>Time from diagnosis to repair.</LI>
<LI>Type of repair used (graft interposition, direct suture).</LI>
<LI>Use of mechanical circulatory support or accessory equipment.</LI>
</UL>
</SUBSECTION>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2015-09-22 08:46:52 +0100" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2015-09-22 08:46:50 +0100" MODIFIED_BY="[Empty name]">
<P>Mortality at 30 days, and at one year.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2015-09-22 08:46:52 +0100" MODIFIED_BY="[Empty name]">
<P>Postoperative and follow-up complications as related to:</P>
<UL>
<LI>Device (stent failure, stent fracture, stent migration); or</LI>
<LI>Procedure (endoleak, pseudoaneurysm formation, paraplegia, cerebrovascular accident, recurrent laryngeal nerve injury, acute renal failure, conversion to open repair).</LI>
</UL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2015-09-22 08:55:33 +0100" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2015-09-22 08:46:55 +0100" MODIFIED_BY="[Empty name]">
<P>The Cochrane Vascular Trials Search Co-ordinator (TSC) searched the Cochrane Register of Studies (CRS) <A HREF="http://www.metaxis.com/CRSWeb/Index.asp">http://www.metaxis.com/CRSWeb/Index.asp</A> (CENTRAL (Issue 7, 2015)). See <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> for details of the search strategy used to search the CRS. The Specialised Register is maintained by the TSC and is constructed from weekly electronic searches of MEDLINE, EMBASE, CINAHL, AMED, and through handsearching relevant journals. The full list of the databases, journals and conference proceedings which have been searched, as well as the search strategies used are described in the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PVD/frame.html">Specialised Register</A> section of the Cochrane Vascular module in the <I>Cochrane Library</I> (<A HREF="http://www.cochranelibrary.com/">http://www.cochranelibrary.com/</A>).</P>
<P>The TSC searched the following trial databases (July 2015) for details of ongoing and unpublished studies, using the terms blunt and aortic; thoracic and transection; trauma and aortic; and trauma and thoracic.</P>
<UL>
<LI>World Health Organization International Clinical Trials Registry at <A HREF="http://apps.who.int/trialsearch/">http://apps.who.int/trialsearch/</A>.</LI>
<LI>ClinicalTrials.gov at <A HREF="http://clinicaltrials.gov/">http://clinicaltrials.gov/</A>.</LI>
<LI>Current Controlled Trials at <A HREF="http://www.controlled-trials.com/">http://www.controlled-trials.com/</A>.</LI>
</UL>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2015-09-22 08:55:33 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the reference lists of relevant articles retrieved by electronic searches for additional citations.<BR/>
</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2015-09-22 13:48:17 +0100" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2015-09-22 08:46:56 +0100" MODIFIED_BY="[Empty name]">
<P>Two review authors (DP and DH) independently selected studies eligible for inclusion in the review. The third review author (PB) resolved disagreements.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2015-09-22 08:47:00 +0100" MODIFIED_BY="[Empty name]">
<P>We planned that two review authors (DP and DH) would independently extract the required data.</P>
<P>Required data include trial design, participant characteristics, therapeutic modalities (surgery or TEVAR), method of diagnosis, time to treatment and information on mortality and morbidity. We planned to review additional information on side effects as reported by each trial. When necessary, we planned to contact the principal authors of included studies to ask for further information. We intended to consult the third review author (PB) to resolve disagreements.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2015-09-22 13:48:17 +0100" MODIFIED_BY="[Empty name]">
<P>We planned that two review authors (DP and DH) would independently assess the methodological rigour and clinical significance of each trial in accordance with the Cochrane 'risk of bias' domain-based assessment (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>), which includes assessment of different domains of eligible trials such as selection bias (random sequence generation, allocation concealment), performance bias (blinding of participants and personnel, blinding of outcome assessment), attrition bias (incomplete outcome data), reporting bias (selective reporting) and other potential sources of bias. We planned to classify the domains as having low risk of bias, unclear risk of bias or high risk of bias according to guidelines provided in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We intended to consult the third review author (PB) for resolution of any disagreements.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2015-09-22 08:47:08 +0100" MODIFIED_BY="[Empty name]">
<P>We planned to pool the data on mortality, morbidity and other available outcomes provided by each trial to obtain an overall estimate of the effectiveness of the thoracic stent graft. We planned to present the data as a weighted mean difference (WMD) with 95% confidence interval (CI). </P>
<P>We planned to perform statistical analysis according to the statistical guidelines for reviews outlined in the Cochrane Vascular Group <A HREF="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/PVD/frame.html">Module</A>.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2015-09-22 08:47:08 +0100" MODIFIED_BY="[Empty name]">
<P>We planned to use the participant as the unit of analysis.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2015-02-18 23:19:59 +0000" MODIFIED_BY="[Empty name]">
<P>We intended to contact authors of respective studies for clarification and extraction of missing data.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2015-09-22 08:47:11 +0100" MODIFIED_BY="[Empty name]">
<P>We intended to evaluate trial heterogeneity using the I<SUP>2 </SUP>statistic, with values &gt; 50% considered to show substantial heterogeneity. If no evidence of substantial statistical heterogeneity was found, we planned to use a fixed-effect model meta-analysis. If substantial statistical heterogeneity was detected, we planned to use a random-effects model meta-analysis.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2015-09-22 08:47:13 +0100" MODIFIED_BY="[Empty name]">
<P>When the number of studies was sufficient, we intended to use forest plots to assess reporting bias. Otherwise, we planned to base assessment of reporting/publication bias for individual studies on comparison of reported study outcomes versus published study protocols.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2015-09-22 08:47:18 +0100" MODIFIED_BY="[Empty name]">
<P>We intended to base all analyses on intention-to-treat data derived from individual clinical trials. We intended to perform a fixed-effect model meta-analysis unless substantial heterogeneity was detected (see also <LINK TAG="HETEROGENEITY_ASSESSMENT" TYPE="SECTION">Assessment of heterogeneity</LINK>).</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2015-09-22 08:47:19 +0100" MODIFIED_BY="[Empty name]">
<P>We did not plan to perform a subgroup analysis because of the natural history of the condition.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2015-09-22 08:47:21 +0100" MODIFIED_BY="[Empty name]">
<P>We intended to perform a sensitivity analysis to assess the quality of included studies. However, we included no studies in this review; therefore, we did not perform subgroup analysis.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2015-09-22 13:49:17 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2015-09-22 13:49:17 +0100" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2015-03-16 20:37:06 +0000" MODIFIED_BY="Karen Welch">
<P>See <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>. </P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2015-09-22 08:47:22 +0100" MODIFIED_BY="[Empty name]">
<P>We found no eligible studies.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2015-09-22 13:49:17 +0100" MODIFIED_BY="[Empty name]">
<P>See <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
<P>We excluded three studies, as we deemed them not relevant to the topic of this review (<LINK REF="STD-ADSORB-Trial" TYPE="STUDY">ADSORB Trial</LINK>; <LINK REF="STD-INSTEAD-Trial" TYPE="STUDY">INSTEAD Trial</LINK>; <LINK REF="STD-Liang_x002d_Wan-2011" TYPE="STUDY">Liang-Wan 2011</LINK>). We excluded the <LINK REF="STD-ADSORB-Trial" TYPE="STUDY">ADSORB Trial</LINK>, as it compares endovascular intervention versus best medical treatment. We excluded the <LINK REF="STD-INSTEAD-Trial" TYPE="STUDY">INSTEAD Trial</LINK> because researchers sought to investigate the benefit of endovascular intervention in type B aortic dissection. We excluded <LINK REF="STD-Liang_x002d_Wan-2011" TYPE="STUDY">Liang-Wan 2011</LINK> because it provides a clinical comparison of two operational methods (replacing ascending aorta + reconstructing aortic arch with triple-branched stent graft; replacing ascending aorta + replacing half aortic arch) used to treat aortic dissection.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2015-09-22 08:47:28 +0100" MODIFIED_BY="[Empty name]">
<P>As we identified no eligible studies, it was not possible to assess risk of bias.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2015-09-22 08:47:29 +0100" MODIFIED_BY="[Empty name]">
<P>We found no eligible studies for inclusion.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2015-09-22 13:58:13 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2015-09-22 08:47:32 +0100" MODIFIED_BY="[Empty name]">
<P>We found no randomised controlled trials undertaken to determine whether use of thoracic endovascular repair (TEVAR) for treatment of blunt traumatic thoracic aortic injury (BTAI) is associated with reduced mortality and morbidity when compared with conventional surgery.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2015-09-22 13:50:25 +0100" MODIFIED_BY="[Empty name]">
<P>We found no randomised controlled trials undertaken to assess the benefits of one treatment over the other.</P>
<P>To undertake a randomised controlled trial to clarify the optimal management of BTAI would be very challenging, first because of the natural history of the condition, which is usually seen in combination with other life-threatening injuries, requirements for urgent intervention and potential difficulties surrounding consent; and second because an adequately powered study of this relatively rare condition would require a multi-centre study, and potential multi-national involvement. Well-conducted observational studies may be useful for guiding the most appropriate management option.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2015-09-22 08:47:41 +0100" MODIFIED_BY="[Empty name]">
<P>We found no studies conducted to address our objectives; therefore, we were unable to assess the quality of the evidence.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2015-09-22 08:47:43 +0100" MODIFIED_BY="[Empty name]">
<P>We found no studies relevant for inclusion in this review. The Cochrane Vascular TSC performed a comprehensive search of the literature, and review authors selected studies in accordance with recommendations provided in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We resolved disagreements by discussion.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2015-09-22 13:58:13 +0100" MODIFIED_BY="[Empty name]">
<P>Use of thoracic endovascular repair (TEVAR) is rapidly expanding, and as experience is gained and devices are improved, trends seem to be pointing towards improved or at least equal outcomes with TEVAR versus open surgical procedures (<LINK REF="REF-Buz-2008" TYPE="REFERENCE">Buz 2008</LINK>; <LINK REF="REF-Ott-2004" TYPE="REFERENCE">Ott 2004</LINK>; <LINK REF="REF-Yamane-2008" TYPE="REFERENCE">Yamane 2008</LINK>).</P>
<P>A meta-analysis identified 17 retrospective cohort studies reporting on a total of 589 participants with traumatic thoracic aortic injury. Of these, 369 were treated with conventional open surgical repair and 220 underwent TEVAR. Those undergoing TEVAR had a higher injury severity score than those undergoing open surgical repair. Periprocedural mortality and 30-day mortality were significantly lower in the TEVAR group, as was the risk of postoperative paraplegia (<LINK REF="REF-Xenos-2008" TYPE="REFERENCE">Xenos 2008</LINK>).</P>
<P>A further meta-analysis by Xenos encompassing thoracic aortic rupture due to ruptured thoracic aneurysm, acute type B aortic dissection, blunt thoracic trauma and penetrating aortic ulcer also indicated that TEVAR was associated with lower periprocedural mortality rates and paraplegia rates when compared with open repair, and that post operative complications rates for cerebrovascular events were equal (<LINK REF="REF-Xenos-2009" TYPE="REFERENCE">Xenos 2009</LINK>).</P>
<P>The American Association for the Surgery of Trauma performed a prospective multi-centre study to assess the efficacy and safety of TEVAR to open repair in patients with BTAI. A total of 193 participants were included in the study, and 125 were selected for TEVAR. Investigators demonstrated better survival outcomes among BTAI patients with and without major extrathoracic injuries following TEVAR when compared to open repair. However, they did observe stent graft-related complications in 20% of TEVAR patients, and 5% of these subsequently underwent open repair. Study authors concluded that TEVAR was associated with lower mortality but this was not without significant risk of device-related complications (<LINK REF="REF-Demetriades-2008" TYPE="REFERENCE">Demetriades 2008</LINK>).</P>
<P>
<LINK REF="REF-Jonker-2010" TYPE="REFERENCE">Jonker 2010</LINK> reported a large statewide analysis of 328 thoracic aortic trauma patients between 2000 and 2007. TEVAR, which was introduced in 2005, overtook open repair in terms of volume in 2006 and 2007. Patients undergoing TEVAR had reported lower rates of death and respiratory complications when compared with those who had open repair. Investigators reported no significant differences in rates of cardiac complications, acute renal failure, paraplegia or cerebrovascular events. However, the authors did describe a 9% rate of both endoleak and distal embolisation in the TEVAR group (<LINK REF="REF-Jonker-2010" TYPE="REFERENCE">Jonker 2010</LINK>).</P>
<P>Another large retrospective cohort analysis (<LINK REF="REF-Azizzadeh-2013" TYPE="REFERENCE">Azizzadeh 2013</LINK>) evaluated 106 participants from a single centre with traumatic thoracic aortic injury between 2002 and 2010. During that time, the centre moved from 100% open repair practice to 100% endovascular repair, and the endovascular group sustained fewer complications and lower risk of in-hospital death. Costs were found to be similar between groups (<LINK REF="REF-Azizzadeh-2013" TYPE="REFERENCE">Azizzadeh 2013</LINK>).</P>
<P>A more recent retrospective multi-centre study including nine Level 1 trauma centres (<LINK REF="REF-DuBose-2015" TYPE="REFERENCE">DuBose 2015</LINK>) supports previous study findings identifying lower aortic-related mortality among TEVAR patients (odds ratio (OR) 0.21, 95% confidence interval (CI) 0.05 to 0.88). Researchers identified higher chest Abbreviated Injury Scale (AIS) scores and grade and injury severity scores as independent predictors of mortality (<LINK REF="REF-DuBose-2015" TYPE="REFERENCE">DuBose 2015</LINK>).</P>
<P>Non-RCT evidence seems to be steering us towards an endovascular approach to traumatic thoracic aortic injury. The largest meta-analysis to date, which included 7768 participants, reported lower mortality and spinal ischaemia rates for the TEVAR group, as well as reduced risk of graft infection and systemic infection when endovascular treatment was compared with open repair (<LINK REF="REF-Murad-2011" TYPE="REFERENCE">Murad 2011</LINK>). The Society for Vascular Surgery has issued guidelines stating that BTAI should be managed through an endovascular technique (<LINK REF="REF-Lee-2011" TYPE="REFERENCE">Lee 2011</LINK>).</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2015-09-22 08:48:15 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2015-09-22 08:48:14 +0100" MODIFIED_BY="[Empty name]">
<P>No randomised controlled trials have sought to determine whether use of TEVAR for treatment of BTAI is associated with reduced mortality and morbidity when compared with conventional open surgery. Despite the lack of RCT evidence, clinicians are moving forward with endovascular treatment of BTAI on the basis of meta-analyses and large clinical series.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2015-09-22 08:48:15 +0100" MODIFIED_BY="[Empty name]">
<P>It is now unlikely that an RCT comparing open and endovascular treatment of BTAI will be undertaken, as most recent evidence points towards clinical benefit derived from endovascular repair. However, as new devices are brought into clinical use, comparative trials would be useful.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2015-09-22 08:48:16 +0100" MODIFIED_BY="[Empty name]">
<P>We thank A Asmat, CN Lee and P Robless for their work on the protocol of this review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2015-09-22 08:48:20 +0100" MODIFIED_BY="[Empty name]">
<P>DP: none known.<BR/>DH: none known.<BR/>PB: none known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2015-09-22 08:48:19 +0100" MODIFIED_BY="[Empty name]">
<P>DP selected studies, assessed the methodological rigour of studies, extracted data and wrote the review.<BR/>DH selected studies, assessed the methodological rigour of studies, extracted data and wrote the review.<BR/>PB resolved conflicts related to methodological quality, extracted data and commented on the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2015-09-22 08:48:25 +0100" MODIFIED_BY="[Empty name]">
<P>In keeping with updated requirements of The Cochrane Collaboration, we will assess the quality of all future included studies using the risk of bias tool as described in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>The title of this review has been changed from 'Thoracic stent graft versus surgery for traumatic thoracic transection' to 'Thoracic endovascular repair (TEVAR) versus open surgery for blunt traumatic thoracic aortic injury', so that all patients who have a thoracic aortic injury will be captured, as well as the thoracic intervention rather than the device used. We have amended the objective of the review and, accordingly, the types of participants included and interventions provided.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2015-09-22 08:55:33 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2015-09-22 08:55:33 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2015-07-16 22:41:13 +0100" MODIFIED_BY="[Empty name]"/>
<EXCLUDED_STUDIES MODIFIED="2015-09-22 08:55:33 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-ADSORB-Trial" MODIFIED="2015-09-22 08:55:33 +0100" MODIFIED_BY="[Empty name]" NAME="ADSORB Trial" YEAR="2012">
<REFERENCE MODIFIED="2015-09-22 08:48:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Brunkwall J, Kasprzak P, Heijmen R, Verhoeven E, von-Tengg-Kobligk H, Taylor P</AU>
<TI>ADSORB - a prospective randomised controlled trial in acute uncomplicated Type B dissection: stent graft induces false channel thrombosis and reduces its false lumen size - 1 year results</TI>
<SO>Abstracts of the European Society for Vascular Surgery XXVI Annual Meeting</SO>
<YR>2012</YR>
<PG>64-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-09-22 08:48:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brunkwall J, Lammer J, Verhoeven E, Taylor P</AU>
<TI>ADSORB: a study on the efficacy of endovascular grafting in uncomplicated acute dissection of the descending aorta</TI>
<SO>European Journal of Vascular and Endovascular Surgery</SO>
<YR>2012</YR>
<VL>44</VL>
<NO>1</NO>
<PG>31-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-09-22 08:55:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Brunkwall J</AU>
<TI>ADSORB: one year results of stent grafts for acute uncomplicated type B dissection</TI>
<SO>Eurointervention</SO>
<YR>2013</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-08-18 10:24:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Lammer J, Brunkwall JS, Taylor PR, Verhoeven EL, Kasprzak P</AU>
<TI>The ADSORB trial: acute dissection treatment with stent graft or best medical therapy</TI>
<SO>Cardiovascular and Interventional Radiology</SO>
<YR>2012</YR>
<VL>35</VL>
<PG>S175</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-INSTEAD-Trial" MODIFIED="2015-09-22 08:55:33 +0100" MODIFIED_BY="[Empty name]" NAME="INSTEAD Trial" YEAR="2005">
<REFERENCE MODIFIED="2015-03-18 10:26:14 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Nienaber C</AU>
<TI>INSTEAD Trial - 3 month data (INvestigation of STEntgrafts in Aortic Dissection)</TI>
<SO>More Vascular and Endovascular Controversies, Charing Cross 28th International Symposium; 2006 Apr 8-11; London</SO>
<PG>(http://bibamed.agcl.com/cx_2006/Sun1615Nienaber.pdf)</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-09-22 08:49:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Nienaber C</AU>
<TI>Long-term (3-5 year) results of the INSTEAD trial shows the benefit of early TEVAR treatment of uncomplicated type B aortic dissections: game changing results</TI>
<SO>Veith 39th Annual Symposium</SO>
<YR>2012</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-03-02 11:28:47 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nienaber C</AU>
<TI>Type B aortic dissection - Intervention vs. best medical treatment</TI>
<SO>Vascular News</SO>
<YR>2006</YR>
<VL>Educational Supplement (VN32)</VL>
<PG>2-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-07-21 10:50:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nienaber CA, Fattori R, Lund G, Dieckmann C, Wolf W, von Kodolitsch Y, et al</AU>
<TI>Nonsurgical reconstruction of thoracic aortic dissection by stent-graft placement</TI>
<SO>New England Journal of Medicine</SO>
<YR>1999</YR>
<VL>340</VL>
<NO>20</NO>
<PG>1539-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-09-22 08:49:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nienaber CA, Kische S, Akin I, Rousseau H, Eggebrecht H, Fattori R, et al</AU>
<TI>Strategies for subacute/chronic type B aortic dissection: the Investigation of Stent Grafts in Patients with type B Aortic Dissection (INSTEAD) trial 1-year outcome</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>2010</YR>
<VL>140</VL>
<NO>6 Suppl</NO>
<PG>S101-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-09-22 08:55:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nienaber CA, Kische S, Rousseau H, Eggebrecht H, Rehders TC, Kundt G, et al</AU>
<TI>Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial</TI>
<SO>Circulation: Cardiovascular Interventions</SO>
<YR>2013</YR>
<VL>6</VL>
<PG>407-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-07-21 10:51:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nienaber CA, Rousseau H, Eggebrecht H, Kische S, Fattori R, Rehders, et al</AU>
<TI>Randomized comparison of strategies for type B aortic dissection: the INvestigation of STEnt Grafts in Aortic Dissection (INSTEAD) trial</TI>
<SO>Circulation</SO>
<YR>2009</YR>
<VL>120</VL>
<NO>25</NO>
<PG>2519-28</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-09-22 08:49:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nienaber CA, Zannetti S, Barbieri B, Kische S, Schareck W, Rehders TC, et al</AU>
<TI>INvestigation of STEnt grafts in patients with type B Aortic Dissection: design of the INSTEAD trial - a prospective, multicenter, European randomized trial</TI>
<SO>American Heart Journal</SO>
<YR>2005</YR>
<VL>149</VL>
<NO>4</NO>
<PG>592-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2015-03-02 11:54:15 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Nienaber NA</AU>
<TI>INSTEAD Trial: INvestigation of STEnt Grafts in Patients With Type B Aortic Dissection</TI>
<SO>https://clinicaltrials.gov/ct2/show/NCT00525356?term=aortic+dissection&amp;rank=2</SO>
<YR>(accessed 27 January 2015)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liang_x002d_Wan-2011" MODIFIED="2015-09-22 08:49:33 +0100" MODIFIED_BY="[Empty name]" NAME="Liang-Wan 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-09-22 08:49:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Liang-Wan C</AU>
<TI>The contrast of the outcome between replacing ascending aorta + reconstructing aortic arch with triple-branched stent graft and replacing ascending aorta +replacing half aortic arch to treat the aortic dissection</TI>
<SO>http://www.chictr.org/en/proj/show.aspx?proj=2291 (accessed 27 January 2015)</SO>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2014-11-21 22:28:04 +0000" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2015-09-22 08:50:25 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2015-09-22 08:50:25 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Azizzadeh-2013" MODIFIED="2015-08-18 10:24:10 +0100" MODIFIED_BY="[Empty name]" NAME="Azizzadeh 2013" TYPE="JOURNAL_ARTICLE">
<AU>Azizzadeh A, Charlton-Ouw KM, Chen Z, Rahbar MH, Estrera AL, Amer H, et al</AU>
<TI>An outcome analysis of endovascular versus open repair of blunt traumatic aortic injuries</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>2013</YR>
<VL>57</VL>
<NO>1</NO>
<PG>108-14; discussion 115</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="23141678"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bavaria-2007" MODIFIED="2015-09-22 08:50:25 +0100" MODIFIED_BY="[Empty name]" NAME="Bavaria 2007" TYPE="JOURNAL_ARTICLE">
<AU>Bavaria JE, Appoo JJ, Makaroun MS, Verter J, Yu ZF, Mitchell RS, et al</AU>
<TI>Endovascular stent grafting versus open surgical repair of descending thoracic aortic aneurysms in low-risk patients: a multicenter comparative trial</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>2007</YR>
<VL>133</VL>
<NO>2</NO>
<PG>369-77</PG>
<IDENTIFIERS MODIFIED="2015-08-18 10:38:26 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-08-18 10:38:26 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17258566"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Buz-2008" MODIFIED="2015-09-22 08:49:48 +0100" MODIFIED_BY="[Empty name]" NAME="Buz 2008" TYPE="JOURNAL_ARTICLE">
<AU>Buz S, Zipfel B, Mulahasanovic S, Pasic M, Weng Y, Hetzer R</AU>
<TI>Conventional surgical repair and endovascular treatment of acute traumatic aortic rupture</TI>
<SO>European Journal of Cardiothoracic Surgery</SO>
<YR>2008</YR>
<VL>33</VL>
<NO>2</NO>
<PG>143-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="18065235"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cowley-1990" MODIFIED="2015-08-18 10:27:22 +0100" MODIFIED_BY="[Empty name]" NAME="Cowley 1990" TYPE="JOURNAL_ARTICLE">
<AU>Cowley RA, Turney SZ, Hankins JR, Rodriguez A, Attar S, Shankar BS</AU>
<TI>Rupture of thoracic aorta caused by blunt trauma: a fifteen year experience</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>1990</YR>
<VL>100</VL>
<NO>5</NO>
<PG>652-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dake-1994" NAME="Dake 1994" TYPE="JOURNAL_ARTICLE">
<AU>Dake MD, Miller DC, Semba CP, Mitchell RS, Walker PJ, Liddell RP</AU>
<TI>Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aneurysms</TI>
<SO>New England Journal of Medicine</SO>
<YR>1994</YR>
<VL>331</VL>
<NO>26</NO>
<PG>1729-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Demetriades-2008" MODIFIED="2015-08-18 10:33:37 +0100" MODIFIED_BY="[Empty name]" NAME="Demetriades 2008" TYPE="JOURNAL_ARTICLE">
<AU>Demetriades D, Velmahos GC, Scalea TM, Jurkovich GJ, Karmy-Jones R, Teixeira PG, et al</AU>
<TI>Operative repair or endovascular stent graft in blunt traumatic thoracic aortic injuries: results of an American Association for the Surgery of Trauma Multicenter Study</TI>
<SO>Journal of Trauma</SO>
<YR>2008</YR>
<VL>64</VL>
<NO>3</NO>
<PG>561-71</PG>
<IDENTIFIERS MODIFIED="2015-08-18 10:30:42 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-08-18 10:30:42 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="18332794"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-DuBose-2015" MODIFIED="2015-08-18 10:42:33 +0100" MODIFIED_BY="[Empty name]" NAME="DuBose 2015" TYPE="JOURNAL_ARTICLE">
<AU>DuBose JJ, Leake SS, Brenner M, Pasley J, O'Callaghan T, Luo-Owen X, et al</AU>
<TI>Contemporary management and outcomes of blunt thoracic aortic injury: a multicenter retrospective study</TI>
<SO>Journal of Trauma and Acute Care Surgery</SO>
<YR>2015</YR>
<VL>78</VL>
<NO>2</NO>
<PG>360-9</PG>
<IDENTIFIERS MODIFIED="2015-08-18 10:35:50 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-08-18 10:35:50 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="25757123"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Feezor-2008" MODIFIED="2015-08-18 10:39:36 +0100" MODIFIED_BY="[Empty name]" NAME="Feezor 2008" TYPE="JOURNAL_ARTICLE">
<AU>Feezor RJ, Martin TD, Hess PJ Jr, Daniels MJ, Beaver TM, Klodell CT, et al</AU>
<TI>Extent of aortic coverage and incidence of spinal cord ischemia after thoracic endovascular aneurysm repair</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>2008</YR>
<VL>86</VL>
<NO>6</NO>
<PG>1809-14</PG>
<IDENTIFIERS MODIFIED="2015-08-18 10:39:36 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-08-18 10:39:36 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19021982"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2015-09-22 08:49:55 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jonker-2010" MODIFIED="2015-08-18 10:42:20 +0100" MODIFIED_BY="[Empty name]" NAME="Jonker 2010" TYPE="JOURNAL_ARTICLE">
<AU>Jonker FH, Giacovelli JK, Muhs BE, Sosa JA, Indes JE</AU>
<TI>Trends and outcomes of endovascular and open treatment for traumatic thoracic aortic injury</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>2010</YR>
<VL>51</VL>
<NO>3</NO>
<PG>565-71</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="20045619"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kato-1997" NAME="Kato 1997" TYPE="JOURNAL_ARTICLE">
<AU>Kato N, Dake MD, Miller DC, Semba CP, Mitchell RS, Razavi MK, et al</AU>
<TI>Traumatic thoracic aneurysm: treatment with endovascular stent-grafts</TI>
<SO>Radiology</SO>
<YR>1997</YR>
<VL>205</VL>
<NO>3</NO>
<PG>657-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lee-2011" MODIFIED="2015-08-18 10:42:06 +0100" MODIFIED_BY="[Empty name]" NAME="Lee 2011" TYPE="JOURNAL_ARTICLE">
<AU>Lee WA, Matsumura JS, Mitchell RS, Farber MA, Greenberg RK, Azizzadeh A, et al</AU>
<TI>Endovascular repair of traumatic thoracic aortic injury: clinical practice guidelines of the Society for Vascular Surgery</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>2011</YR>
<VL>53</VL>
<NO>1</NO>
<PG>187-92</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="20974523"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Murad-2011" MODIFIED="2015-09-22 08:50:04 +0100" MODIFIED_BY="[Empty name]" NAME="Murad 2011" TYPE="JOURNAL_ARTICLE">
<AU>Murad MH, Rizvi AZ, Malgor R, Carey J, Alkatib AA, Erwin PJ, et al</AU>
<TI>Comparative effectiveness of the treatments for thoracic aortic transection [corrected]</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>2011</YR>
<VL>53</VL>
<NO>1</NO>
<PG>193-9.e1-21</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="21035988"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nagy-2000" MODIFIED="2015-09-22 08:50:10 +0100" MODIFIED_BY="[Empty name]" NAME="Nagy 2000" TYPE="JOURNAL_ARTICLE">
<AU>Nagy K, Fabian T, Rodman G, Fulda G, Rodriguez A, Mirvis S</AU>
<TI>Guidelines for the diagnosis and management of blunt aortic injury: an EAST Practice Management Guidelines Work Group</TI>
<SO>Journal of Trauma</SO>
<YR>2000</YR>
<VL>48</VL>
<NO>6</NO>
<PG>1128-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-O_x0027_Conner-2004" MODIFIED="2015-01-08 15:15:03 +0000" MODIFIED_BY="[Empty name]" NAME="O'Conner 2004" TYPE="JOURNAL_ARTICLE">
<AU>O'Conner CE</AU>
<TI>Diagnosing traumatic rupture of the thoracic aorta in the emergency department</TI>
<SO>Emergeny Medicne Journal</SO>
<YR>2004</YR>
<VL>21</VL>
<PG>414-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Orford-2003" NAME="Orford 2003" TYPE="JOURNAL_ARTICLE">
<AU>Orford VP, Atkinson NR, Thomson K, Milne PY, Campbell WA, Roberts A, et al</AU>
<TI>Blunt traumatic aortic transection: the endovascular experience</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>2003</YR>
<VL>75</VL>
<NO>1</NO>
<PG>106-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ott-2004" MODIFIED="2015-08-18 10:39:57 +0100" MODIFIED_BY="[Empty name]" NAME="Ott 2004" TYPE="JOURNAL_ARTICLE">
<AU>Ott MC, Stewart TC, Lawlor DK, Gray DK, Forbes TL</AU>
<TI>Management of blunt thoracic aortic injuries: endovascular stents versus open repair</TI>
<SO>Journal of Trauma</SO>
<YR>2004</YR>
<VL>56</VL>
<NO>3</NO>
<PG>565-70</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="15128128"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Parodi-1991" NAME="Parodi 1991" TYPE="JOURNAL_ARTICLE">
<AU>Parodi JC, Palmaz JC, Barone HD</AU>
<TI>Transfemoral intraluminal graft implantation for abdominal aortic aneurysms</TI>
<SO>Annals of Vascular Surgery</SO>
<YR>1991</YR>
<VL>5</VL>
<NO>6</NO>
<PG>491-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Passaro-1959" NAME="Passaro 1959" TYPE="JOURNAL_ARTICLE">
<AU>Passaro E, Pace WG</AU>
<TI>Traumatic rupture of the aorta</TI>
<SO>Surgery</SO>
<YR>1959</YR>
<VL>46</VL>
<PG>787-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tehrani-2006" MODIFIED="2015-08-18 10:40:09 +0100" MODIFIED_BY="[Empty name]" NAME="Tehrani 2006" TYPE="JOURNAL_ARTICLE">
<AU>Tehrani HY, Peterson BG, Katariya K, Morasch MD, Stevens R, DiLuozzo G, et al</AU>
<TI>Endovascular repair of thoracic aortic tears</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>2006</YR>
<VL>82</VL>
<NO>3</NO>
<PG>873-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-von-Oppell-1994" NAME="von Oppell 1994" TYPE="JOURNAL_ARTICLE">
<AU>von Oppell UO, Dunne TT, De Groot MK, Zilla P</AU>
<TI>Traumatic aortic rupture: twenty year meta-analysis of mortality and risk of paraplegia</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1994</YR>
<VL>58</VL>
<NO>2</NO>
<PG>585-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Xenos-2008" MODIFIED="2015-08-18 10:40:20 +0100" MODIFIED_BY="[Empty name]" NAME="Xenos 2008" TYPE="JOURNAL_ARTICLE">
<AU>Xenos ES, Abedi NN, Davenport DL, Minion DJ, Hamdallah O, Sorial EE, et al</AU>
<TI>Meta-analysis of endovascular vs open repair for traumatic descending thoracic aortic rupture</TI>
<SO>Journal of Vascular Surgery</SO>
<YR>2008</YR>
<VL>48</VL>
<NO>5</NO>
<PG>1343-51</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="18632242"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Xenos-2009" MODIFIED="2015-08-18 10:40:39 +0100" MODIFIED_BY="[Empty name]" NAME="Xenos 2009" TYPE="JOURNAL_ARTICLE">
<AU>Xenos ES, Minion DJ, Davenport DL, Hamdallah O, Abedi NN, Sorial EE, et al</AU>
<TI>Endovascular versus open repair for descending thoracic aortic rupture: institutional experience and meta-analysis</TI>
<SO>European Journal of Cardio-Thoracic Surgery</SO>
<YR>2009</YR>
<VL>35</VL>
<NO>2</NO>
<PG>282-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="19081731"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Yamane-2008" MODIFIED="2015-01-08 15:30:02 +0000" MODIFIED_BY="[Empty name]" NAME="Yamane 2008" TYPE="JOURNAL_ARTICLE">
<AU>Yamane BH, Tefera G, Hoch JR, Turnipseed WD, Acher CW</AU>
<TI>Blunt thoracic aortic injury: open or stent graft repair?</TI>
<SO>Surgery</SO>
<YR>2008</YR>
<VL>144</VL>
<NO>4</NO>
<PG>575-80; discussion 580-2</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="18847641"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2015-03-02 11:55:01 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Asmat-2007" MODIFIED="2015-03-02 11:55:01 +0000" MODIFIED_BY="[Empty name]" NAME="Asmat 2007" TYPE="COCHRANE_PROTOCOL">
<AU>Asmat A, Lee CN, Robless P</AU>
<TI>Thoracic stent graft versus surgery for traumatic thoracic transection</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2015-01-27 15:23:25 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2015-01-27 15:23:25 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006642"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2015-02-25 10:58:03 +0000" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2015-09-22 08:48:28 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2015-07-16 22:41:13 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2015-09-22 08:48:28 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2015-09-22 08:48:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-ADSORB-Trial">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-09-22 08:48:26 +0100" MODIFIED_BY="[Empty name]">
<P>ADSORB trial compares endovascular intervention versus best medical treatment. This is not the aim of the review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-09-22 08:48:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-INSTEAD-Trial">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-09-22 08:48:27 +0100" MODIFIED_BY="[Empty name]">
<P>INSTEAD trial investigates benefits of endovascular intervention in type B aortic dissection. This is not the aim of the review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-09-22 08:48:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liang_x002d_Wan-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-09-22 08:48:28 +0100" MODIFIED_BY="[Empty name]">
<P>A clinical comparison of 2 operational methods (replacing ascending aorta + reconstructing aortic arch with triple-branched stent graft and replacing ascending aorta + replacing half aortic arch to treat the aortic dissection). This study does not reflect the aims of this review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2014-11-21 22:28:04 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2015-07-16 22:41:13 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2015-07-16 22:41:13 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2015-07-16 22:41:13 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2015-07-16 22:41:13 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2015-07-16 22:41:13 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2015-07-16 22:41:13 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2015-07-16 22:41:13 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2015-07-16 22:41:13 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES"/>
<FIGURES MODIFIED="2015-09-22 08:58:29 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2015-09-22 08:58:29 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAvYAAAQ5CAYAAACpj0t7AACAAElEQVR42uzdcURf/eP//w/JJJMx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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2015-07-30 16:34:44 +0100" MODIFIED_BY="Karen Welch">
<APPENDIX ID="APP-01" MODIFIED="2015-07-30 16:34:44 +0100" MODIFIED_BY="Karen Welch" NO="1">
<TITLE MODIFIED="2015-07-30 16:34:44 +0100" MODIFIED_BY="Karen Welch">CRS search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2015-07-30 16:34:26 +0100" MODIFIED_BY="Karen Welch">
<TABLE COLS="3" ROWS="19">
<TR>
<TD>
<P>#1</P>
</TD>
<TD>
<P>MESH DESCRIPTOR Aorta, Thoracic EXPLODE ALL TREES WITH QUALIFIERS IN,SU</P>
</TD>
<TD ALIGN="RIGHT">
<P>30</P>
</TD>
</TR>
<TR>
<TD>
<P>#2</P>
</TD>
<TD>
<P>MESH DESCRIPTOR Aortic Rupture EXPLODE ALL TREES WITH QUALIFIERS SU</P>
</TD>
<TD ALIGN="RIGHT">
<P>31</P>
</TD>
</TR>
<TR>
<TD>
<P>#3</P>
</TD>
<TD>
<P>MESH DESCRIPTOR Thoracic Injuries EXPLODE ALL TREES WITH QUALIFIERS SU</P>
</TD>
<TD ALIGN="RIGHT">
<P>19</P>
</TD>
</TR>
<TR>
<TD>
<P>#4</P>
</TD>
<TD>
<P>(aort* near3 (transect* or disrupt* or tear or torn or rupture* or injur*)):TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>95</P>
</TD>
</TR>
<TR>
<TD>
<P>#5</P>
</TD>
<TD>
<P>(thora* near3 (transect* or disrupt* or tear or torn or rupture* or injur*)):TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>194</P>
</TD>
</TR>
<TR>
<TD>
<P>#6</P>
</TD>
<TD>
<P>(thora* near5 repair):TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>41</P>
</TD>
</TR>
<TR>
<TD>
<P>#7</P>
</TD>
<TD>
<P>(trauma* near5 thoracic):TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>22</P>
</TD>
</TR>
<TR>
<TD>
<P>#8</P>
</TD>
<TD>
<P>#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7</P>
</TD>
<TD ALIGN="RIGHT">
<P>364</P>
</TD>
</TR>
<TR>
<TD>
<P>#9</P>
</TD>
<TD>
<P>MESH DESCRIPTOR Stents EXPLODE ALL TREES</P>
</TD>
<TD ALIGN="RIGHT">
<P>2713</P>
</TD>
</TR>
<TR>
<TD>
<P>#10</P>
</TD>
<TD>
<P>MESH DESCRIPTOR Thoracic Surgery EXPLODE ALL TREES</P>
</TD>
<TD ALIGN="RIGHT">
<P>140</P>
</TD>
</TR>
<TR>
<TD>
<P>#11</P>
</TD>
<TD>
<P>MESH DESCRIPTOR Blood Vessel Prosthesis EXPLODE ALL TREES</P>
</TD>
<TD ALIGN="RIGHT">
<P>384</P>
</TD>
</TR>
<TR>
<TD>
<P>#12</P>
</TD>
<TD>
<P>MESH DESCRIPTOR Blood Vessel Prosthesis Implantation EXPLODE ALL TREES</P>
</TD>
<TD ALIGN="RIGHT">
<P>366</P>
</TD>
</TR>
<TR>
<TD>
<P>#13</P>
</TD>
<TD>
<P>(*stent* or graft* or tevar or endograft* or endograft* or endoprosthe*):TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>52030</P>
</TD>
</TR>
<TR>
<TD>
<P>#14</P>
</TD>
<TD>
<P>(powerlink or talent or excluder or aorfix or zenith or endologix or anaconda or Triascular or Cordis or Endurant or Quantum or Aneurx or Ancurepowerlink or anaconda or Ancure or Advanta or Intracoil or Zilver or Luminex):TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>385</P>
</TD>
</TR>
<TR>
<TD>
<P>#15</P>
</TD>
<TD>
<P>endovascular:TI,AB,KY</P>
</TD>
<TD ALIGN="RIGHT">
<P>986</P>
</TD>
</TR>
<TR>
<TD>
<P>#16</P>
</TD>
<TD>
<P>MESH DESCRIPTOR Vascular Surgical Procedures</P>
</TD>
<TD ALIGN="RIGHT">
<P>480</P>
</TD>
</TR>
<TR>
<TD>
<P>#17</P>
</TD>
<TD>
<P>MESH DESCRIPTOR Endovascular Procedures EXPLODE ALL TREES</P>
</TD>
<TD ALIGN="RIGHT">
<P>5523</P>
</TD>
</TR>
<TR>
<TD>
<P>#18</P>
</TD>
<TD>
<P>#9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17</P>
</TD>
<TD ALIGN="RIGHT">
<P>56570</P>
</TD>
</TR>
<TR>
<TD>
<P>#19</P>
</TD>
<TD>
<P>#8 AND #18</P>
</TD>
<TD ALIGN="RIGHT">
<P>103</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;0 studies included in quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="191">
<FLOWCHARTBOX TEXT="&lt;p&gt;0 studies included in qualitative synthesis&lt;/p&gt;" WIDTH="194">
<FLOWCHARTBOX TEXT="&lt;p&gt;14 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="196">
<FLOWCHARTBOX TEXT="&lt;p&gt;29 reports screened by authors&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;736 reports screened by TSC&lt;/p&gt;" WIDTH="198">
<FLOWCHARTBOX TEXT="&lt;p&gt;736 reports after duplicates removed&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;103 reports from CRS search&lt;/p&gt;&lt;p&gt;CT.gov&lt;/p&gt;&lt;p&gt;6 studies found for: blunt and aortic&lt;/p&gt;&lt;p&gt;15 studies found for: thoracic and transection&lt;/p&gt;&lt;p&gt;146 studies found for: trauma and aortic&lt;/p&gt;&lt;p&gt;633 studies found for: trauma and thoracic&lt;/p&gt;&lt;p&gt;WHO&lt;/p&gt;&lt;p&gt;6 records for 6 trials found for: blunt and aortic&lt;/p&gt;&lt;p&gt;3 records for 3 trials found for: thoracic and transection &lt;/p&gt;&lt;p&gt;13 records for 12 trials found for: trauma and aortic &lt;/p&gt;&lt;p&gt;62 records for 60 trials found for: trauma and thoracic&lt;/p&gt;&lt;p&gt;ISRCTN&lt;/p&gt;&lt;p&gt;1 results blunt and aortic&lt;/p&gt;&lt;p&gt;No results found for thoracic and transection&lt;/p&gt;&lt;p&gt;10 results trauma and aortic&lt;/p&gt;&lt;p&gt;14 results trauma and thoracic&lt;/p&gt;" WIDTH="410"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;29 reports from the Specialised Register&lt;/p&gt;" WIDTH="186"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;707 reports not relevant for this review&lt;/p&gt;" WIDTH="202"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;15 reports assessed as not relevant for this review&lt;/p&gt;"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;3 studies (14 full-text articles) excluded, with reasons&lt;/p&gt;" WIDTH="200"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>